导航菜单
基本情况
四川大学华西公共卫生学院/华西第四医院博士后，研究兴趣聚焦于创新卫生技术评估、监管和准入，论文发表于PLoS Medicine，The Lancet Regional Health -Western Pacific，International Journal of Health Policy and Management等学术期刊
工作经历
2025/01-至今 四川大学华西公共卫生学院/华西第四医院博士后
研究方向(含承担课题)
卫生技术评估、监管与准入
著作论文
[1] Zhou J, Lan T, Lu H, Pan J. Price negotiation and pricing of anticancer drugs in China: An observational study. PLoS Medicine. 2024; 21(1): e1004332.
[2] Pan J, Wei X, Lu H, Wu X, Li C, Hai X, Lan T, Dong Q, Yang Y, Jakovljevic M, Zhou J. List prices and clinical value of anticancer drugs in China, Japan, and South Korea: A retrospective comparative study. The Lancet Regional Health - Western Pacific. 2024; 47:101088.
[3] Zhou J, Lu H, Pan J. Association of launch price and clinical value with reimbursement decisions for anticancer drugs in China. International Journal of Health Policy and Management. 2024; 13:8150.
学术兼职
四川省药学会循证药学专业委员会委员（2023-至今）